ORCHARD THERAPEUTICS PLC Retained Earnings
ORCHARD THERAPEUTICS PLC had Retained Earnings of -$965.92 million as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2023-11-13
- 2023-09-30: Retained Earnings (Accumulated Deficit) -$965.92M.
- 2023-06-30: Retained Earnings (Accumulated Deficit) -$930.60M.
- 2023-03-31: Retained Earnings (Accumulated Deficit) -$918.30M.
- 2022-12-31: Retained Earnings (Accumulated Deficit) -$900.88M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2023-09-30 | -$965.92M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$930.60M 10-Q · filed 2023-08-10 |
| 2023-03-31 | -$918.30M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$900.88M 10-Q · filed 2023-11-13 |
| 2022-09-30 | -$893.00M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$845.44M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$794.52M 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$750.22M 10-K · filed 2023-03-14 |
| 2021-09-30 | -$713.88M 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$677.43M 10-Q · filed 2021-08-04 |
| 2021-03-31 | -$640.82M 10-Q · filed 2021-05-13 |
| 2020-12-31 | -$605.64M 10-K · filed 2022-03-30 |
| 2020-09-30 | -$572.02M 10-Q · filed 2020-11-03 |
| 2020-06-30 | -$551.73M 10-Q · filed 2020-08-06 |
| 2020-03-31 | -$504.23M 10-Q · filed 2020-05-07 |
| 2019-12-31 | -$453.66M 10-K · filed 2021-03-02 |
| 2019-09-30 | -$408.25M 6-K · filed 2019-11-07 |
| 2019-06-30 | -$371.51M 6-K · filed 2019-08-08 |
| 2019-03-31 | -$320.98M 6-K · filed 2019-05-28 |
| 2018-12-31 | -$290.24M 10-K · filed 2020-02-27 |
| 2017-12-31 | -$59.74M 20-F · filed 2019-03-22 |